Rajiv Paudel, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1550 Faulk St, Ste 3100, Monroe, NC 28112 Phone: 704-667-3410 |
Dr. James Wayne Roberts, MD Internal Medicine - Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 1640 E Roosevelt Blvd, Monroe, NC 28112 Phone: 704-226-0500 Fax: 704-226-0599 |
Dr. Martin John Kreshon Jr., MD Internal Medicine - Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 1640 E Roosevelt Blvd, Monroe, NC 28112 Phone: 704-226-0599 Fax: 704-226-0599 |
Dr. Innanje Ravindranath Rao, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1423 E Franklin St, Suite B, Monroe, NC 28112 Phone: 704-283-6953 Fax: 704-283-0228 |
Jens Eichhorn, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1550 Faulk St, Ste 3100, Monroe, NC 28112 Phone: 704-667-3410 |
Ann Torian Bradsher, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1550 Faulk St, Suite 3100, Monroe, NC 28112 Phone: 704-283-1990 Fax: 704-289-5299 |
News Archive
Cannasat Therapeutics Inc., a clinical stage pharmaceutical company developing products to treat neurological disorders such as neuropathic pain and schizophrenia, today announced its results for the six months ended June 30, 2009. Unless specified otherwise, all amounts are in Canadian dollars.
New Mayo Clinic research suggests that blood may hold clues to whether post-menopausal women may be at an increased risk for areas of brain damage that can lead to memory problems and possibly increased risk of stroke. The study shows that blood's tendency to clot may contribute to areas of brain damage called white matter hyperintensities.
Zargis Medical Corp., a spin-off from Siemens Corporate Research (NYSE: SI) and a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE), today announced that it has begun selling its Zargis Cardioscan(TM) heart sound analysis software, along with 3M's (NYSE: MMM) just-released Bluetooth(R)-enabled 3M(TM) Littmann(R) Electronic Stethoscope Model 3200, as part of its previously announced exclusive multi-year global marketing alliance with 3M.
Resverlogix Corp. today announces the "Mechanism of Action" (MoA) by which RVX-208 increases apolipoprotein A-I (ApoA-I) production.
› Verified 3 days ago